Folate receptor 1 antibodies and immunoconjugates and uses thereof
US10301385B2 · kind B2 · utility
4Cited by
22References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2017 |
| Grant date | May 28, 2019 |
| Priority date | — |
| Expiry date | Jun 7, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to human folate receptor 1 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.